In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers.

Our moderator, Dr. Ken Park, is joined by an exceptional group of speakers: Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals; Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea; and Alaric Jackson, Chief Technology and Data Officer at Fortrea.